Abstract 2133: KA-2887-LD38: a novel bispecific antibody-drug conjugate (ADC) targeting both EGFR and PD-L1
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Guojin Wu, Chuanying Xu, Weihong Nian, Zhengcheng Guo, Jiabei Liang, Feng He, Qing Zhou, Jinying Ning
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409630814